Mitomycin-C (MMC) in combination with capecitabine (mixel) as third line chemotherapy in anthracycline and taxane pretreated metastatic breast cancer patients (MBC): Results of pilot study
ANNALS OF ONCOLOGY（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要